Chongqing Pharscin Pharmaceutical Co., Ltd. (002907.SZ)

Home
002907.SZ
Financials

16.07 (CNY) • At close October 26, 2023

Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2018 Q4	2018 Q3	2018 Q2	2018 Q1	2017 Q4	2017 Q3	2017 Q2	2017 Q1	2016 Q4	2016 Q1
Revenue Numbers are in millions	196.371	185.462	228.393	176.285	154.802	172.916	187.539	223.493	194.062	164.642	202.986	200.8	209.605	205.735	230.001	257.53	245.458	208.96	170.527	215.494	221.121	213.758	191.691	169.175	180.939	188.386	164.916	151.317	156.163	158.627	125.987	160.9	131.087
Cost of Revenue Numbers are in millions	83.918	93.39	89.844	88.694	68.205	80.011	74.438	88.17	74.545	66.758	89.819	102.159	91.535	94.398	111.833	150.21	130.563	108.027	69.506	83.566	76.997	81.341	65.182	53.999	54.52	67.918	54.334	50.655	47.063	54.497	43.146	61.556	46.413
Gross Profit Numbers are in millions	112.453	92.072	138.549	87.591	86.597	92.906	113.101	135.323	119.517	97.884	113.167	98.642	118.07	111.337	118.168	107.32	114.895	100.932	101.021	131.929	144.125	132.417	126.509	115.176	126.419	120.468	110.582	100.662	109.1	104.13	82.842	99.345	84.675
Gross Profit Ratio Numbers are in millions	0.573	0.496	0.607	0.497	0.559	0.537	0.603	0.605	0.616	0.595	0.558	0.491	0.563	0.541	0.514	0.417	0.468	0.483	0.592	0.612	0.652	0.619	0.66	0.681	0.699	0.639	0.671	0.665	0.699	0.656	0.658	0.617	0.646
Reseach & Development Expenses Numbers are in millions	13.144	11.255	12.645	28.718	20.488	14.762	14.152	19.916	17.678	12.294	8.934	16.358	8.261	10.49	6.612	13.538	9.441	8.631	4.868	9.812	6.403	2.964	6.379	6.466	2.775	4.607	1.467	4.507	1.436	5.129	0	4.064	0
General & Administrative Expenses Numbers are in millions	35.33	-7.056	12.759	-27.255	32.707	-7.189	11.65	-23.61	27.959	-5.738	9.53	-23.771	23.597	-3.959	9.253	-18.719	9.903	-3.421	10.232	-17	10.685	-4.459	8.343	-16.51	7.761	-7.244	10.23	-14.577	7.446	-4.994	7.716	-12.468	7.394
Selling & Marketing Expenses Numbers are in millions	88.638	65.685	68.013	52.982	48.049	56.779	52.929	75.024	65.287	51.279	54.345	78.859	65.371	59.233	55.128	63.818	58.605	53.767	48.955	72.639	74.251	71.465	72.434	70.276	75.117	68.495	65.454	65.653	60.651	65.224	47.73	61.562	47.586
SG&A Numbers are in millions	123.968	74.638	80.772	25.726	80.757	49.59	64.579	51.414	93.247	45.541	63.875	55.088	88.968	55.274	64.381	45.099	68.509	50.346	59.187	55.638	84.936	67.006	80.777	53.765	82.878	61.251	75.684	51.076	68.097	60.23	55.446	49.095	54.98
Other Expenses Numbers are in millions	-56.074	-0.329	0.021	-2.847	-0.236	0.027	0.181	39.611	-16.928	11.006	0.313	0.027	0.012	0.053	0.016	0.036	-0.024	-0.248	-0.153	0.07	-0.204	-0.181	0.044	-0.237	0.314	0.329	2.031	0.927	0.087	-0.062	0.357	4.521	0.822
Operating Expenses Numbers are in millions	81.038	86.222	91.859	96.274	80.503	83.367	78.912	110.941	93.996	68.841	73.122	102.445	82.728	82.891	71.535	84.889	77.004	59.372	64.381	95.066	88.915	60.652	89.229	86.217	66.943	83.431	77.756	78.407	54.813	75.068	57.356	76.521	56.853
Operating Income Numbers are in millions	31.416	5.85	48.045	-5.872	4.551	11.397	35.747	26.476	20.833	26.938	34.582	-1.592	38.711	23.553	42.639	25.533	37.452	41.549	32.903	35.622	54.077	71.738	36.826	28.889	58.186	38.61	32.786	22.754	53.986	30.138	24.174	20.909	25.249
Operating Income Ratio Numbers are in millions	0.16	0.032	0.21	-0.033	0.029	0.066	0.191	0.118	0.107	0.164	0.17	-0.008	0.185	0.114	0.185	0.099	0.153	0.199	0.193	0.165	0.245	0.336	0.192	0.171	0.322	0.205	0.199	0.15	0.346	0.19	0.192	0.13	0.193
Total Other Income Expenses Net Numbers are in millions	1.011	3.284	0.021	-2.847	-0.236	0.027	0.029	-0.219	0.05	-0.173	-0.247	0.027	0.012	0.053	0.016	0.036	-0.024	-0.248	-0.153	0.07	-0.204	-0.181	0.044	-0.237	0.314	0.329	2.031	0.928	0.087	-0.047	0.357	2.807	0.822
Income Before Tax Numbers are in millions	32.427	11.63	48.066	-8.719	4.315	11.425	35.776	26.257	20.884	26.765	34.335	-1.564	38.722	23.607	42.655	25.57	37.429	41.3	32.75	35.692	53.873	71.557	36.87	28.652	58.499	38.939	34.816	23.684	54.073	30.091	24.531	23.716	26.071
Income Before Tax Ratio Numbers are in millions	0.165	0.063	0.21	-0.049	0.028	0.066	0.191	0.117	0.108	0.163	0.169	-0.008	0.185	0.115	0.185	0.099	0.152	0.198	0.192	0.166	0.244	0.335	0.192	0.169	0.323	0.207	0.211	0.157	0.346	0.19	0.195	0.147	0.199
Income Tax Expense Numbers are in millions	4.111	2.27	7.715	3.357	0.902	0.163	5.675	0.704	0.01	4.142	4.984	-3.908	5.555	3.812	6.181	1.163	5.479	6.316	4.903	3.71	8.2	10.697	5.639	3.296	8.785	6.087	5.367	4.45	7.438	5.612	2.891	4.829	3.892
Net Income Numbers are in millions	27.362	6.864	40.351	-12.076	3.413	11.262	30.101	25.554	20.874	22.623	29.351	2.344	33.168	19.795	36.474	24.406	31.95	34.985	27.847	31.982	45.673	60.86	31.231	25.356	49.714	32.852	29.449	19.233	46.635	24.479	21.639	18.887	22.179
Net Income Ratio Numbers are in millions	0.139	0.037	0.177	-0.069	0.022	0.065	0.161	0.114	0.108	0.137	0.145	0.012	0.158	0.096	0.159	0.095	0.13	0.167	0.163	0.148	0.207	0.285	0.163	0.15	0.275	0.174	0.179	0.127	0.299	0.154	0.172	0.117	0.169
EPS Numbers are in millions	0.066	0.016	0.097	-0.029	0.008	0.027	0.072	0.063	0.052	0.056	0.073	0.006	0.083	0.049	0.091	0.061	0.08	0.087	0.07	0.08	0.11	0.15	0.078	0.063	0.12	0.082	0.074	0.053	0.13	0.068	0.06	0.053	0.062
EPS Diluted Numbers are in millions	0.066	0.016	0.097	-0.029	0.008	0.027	0.072	0.063	0.052	0.056	0.073	0.006	0.083	0.049	0.091	0.061	0.08	0.087	0.07	0.08	0.11	0.15	0.078	0.063	0.12	0.082	0.074	0.053	0.13	0.068	0.06	0.053	0.062
EBITDA Numbers are in millions	31.124	32.907	69.711	15.15	28.11	32.583	57.183	45.495	45.077	51.364	55.516	20.342	62.064	42.214	64.002	42.499	41.774	55.88	40.242	45.381	63.573	72.059	42.596	29.202	60.8	41.143	34.857	28.835	54.338	29.776	26.564	40.397	30.126
EBITDA Ratio Numbers are in millions	0.158	0.146	0.217	-0.067	0.033	0.062	0.191	0.121	0.139	0.188	0.201	0.004	0.194	0.15	0.211	0.105	0.176	0.21	0.226	0.177	0.257	0.337	0.2	0.175	0.336	0.219	0.209	0.164	0.35	0.182	0.211	0.261	0.23

Chongqing Pharscin Pharmaceutical Co., Ltd.

SZSE:002907.SZ Add to watchlist

SZSE:002907.SZ